Izidore Lossos, Md

This study is testing an investigational drug called epcoritamab in adults who have just been diagnosed with marginal zone lymphoma (MZL) and have not yet received any treatment. The main goal is to see how many participants achieve a complete response, meaning no detectable canc…

This study is testing whether the medication mosunetuzumab can help people with newly diagnosed extranodal marginal zone lymphoma (EMZL) who haven't received any cancer treatment yet. The trial will enroll 35 adults with stage I-IV disease to see how well the drug works at elimin…